Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision from v3.4.0 to v3.4.1 appears to be a version update with no visible changes to study content or structure on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision from v3.3.3 to v3.3.4; no substantive changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a dedicated Locations section highlighting Illinois as a study site. Removed the separate Illinois Locations entry and the HHS Vulnerability Disclosure link in the prior revision.SummaryDifference0.2%

- Check78 days agoChange DetectedMinor backend version updates (from v3.2.0 to v3.3.2) with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedDeletion of the site-wide notice about a lapse in government funding and NIH Clinical Center status; it does not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.